Advanced Filters
noise

Taipei 105, Taiwan Clinical Trials

A listing of Taipei 105, Taiwan clinical trials actively recruiting patients volunteers.

Found 778 clinical trials
I I-Rue Lai, MDPHD

Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis

Background: Approximately 15% of gastric adenocarcinoma patients presents with peritoneal carcinomatosis (PC) at the first encounter and is regarded as an unresectable and end-stage disease. The recommended treatment with palliative chemotherapy alone yields a poor clinical efficacy. Emerging evidences suggest the survival benefits of complete cytoreductive surgery (CRS) combined with …

20 - 75 years of age All Phase N/A
M Meng Ting Lin, M.D.

Individualized rTMS for Motor Recovery in Stroke Patients

This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.

20 years of age All Phase N/A
W Wan-Ching Lien

Evaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke

The investigators evaluate the vocal cord movement in patients with acute stroke by ultrasound. The occurrence of choking or aspiration pneumonia will be collected in one year after the index stroke.

20 years of age All Phase N/A
C Christy Lee

A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck

This phase II study is a randomized, double-blind study that seeks to evaluate the clinical effects and safety of fucoidan in the treatment of cancer patients with stage III/IV head and neck squamous cell carcinoma. Patients will be centrally randomized in a 1:1 ratio to receive either Fucoidan or placebo …

20 - 75 years of age All Phase 2
C CHYI-FENG JAN, MD, PhD

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer<10 mIU/mL) need to take.

20 - 36 years of age All Phase N/A

CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma

CVM-1118 is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by TaiRx, Inc. CVM-1118 is a potent anti-cancer agent in numerous human cancer cell lines. The safety of administrating CVM-1118 on human has been evaluated from the phase 1 study. The objective of the phase …

18 years of age All Phase 2

Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial

The purpose of this study is to evaluate the efficacy and safety of pentosan polysulfate sodium versus placebo and in patients with radiation cystitis who have received radiation therapy in pelvic region.

20 years of age All Phase 2/3
C CHIN-YU LIN

Waveform Periodicity Analysis in Patients With Persistent Atrial Fibrillation

STUDY DESIGN A prospective study. OBJECTIVE A single center clinical trial on the analysis of intracardiac atrial electrogram waveform periodicity for catheter ablation of persistent atrial fibrillation with OCTARAY™ Mapping Catheter, as prospective randomized controlled study. HYPOTHESIS The critical atrial substrates in maintaining persistent atrial fibrillation could be identified by …

20 - 80 years of age All Phase N/A
S Shao-Yu Tsai

Sleep Health Care in Pregnancy: A Randomized Controlled Trial

Sleep disturbances are one of the most frequent complaints brought to the healthcare professionals during routine prenatal care visits.The purpose of this study is to develop and evaluate a Sleep Training and Education Program (STEP) for improving sleep and health in women during pregnancy.

20 - 45 years of age Female Phase N/A
S Shin-Joe Yeh, MD PhD

Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage

This trial is a phase IIa human clinical study, in which 60 patients with intracerebral hemorrhage (ICH) at basal ganglion or thalamus within 6 h after onset will be enrolled. Patients will be randomly assigned as treatment group or control group as 1:1 distribution. Early initiation of celecoxib within 6 …

20 - 80 years of age All Phase 2

Simplify language using AI